EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›CENT

CENT

CENTRAL GARDEN & PET CO

Next earnings Aug 4, 2026 · consensus $1.54 EPS, $914M rev

Last earnings +2.1% on 2026-05-06

Hold
$44.60
▼ -0.69%
$44.60▲ +26.78%
over 1Y
L $28.98EODHDH $45.15
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-0.7%
1W+3.8%
1M+15.3%
3M+20.2%
YTD+39.6%
1Y+26.8%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
B
Valuation
Undervalued
Filings
Clean
Hold
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••
Street · 11 analysts
Buy

Quality self-help story: margins and EPS surging on cost cuts, but revenue's fallen four straight years — fair price, own don't chase.

Diluted EPS $2.55 · FY2025

The read

Middling fundamentals offset by an attractive price (~117% below fair value) — worth a look on the value angle.

CENT is executing a credible self-help turnaround at the profit line while the top line keeps shrinking. FY2025 revenue fell 2.2% to $3.13B — the fourth straight year of decline from the FY2022 peak of $3.34B, with both segments down (Pet -1.7%, Garden -3.0%). Yet gross margin expanded 240bps to 31.9% (from 29.5%), operating income jumped 34.9% to $250M, and diluted EPS rose 57.4% to $2.55. The MD&A is explicit that this is cost- and margin-driven, not demand-driven: the UK wind-down (~$10M one-time cost) shifts Europe to a lower-overhead export model, and the Ontario/Salt Lake City distribution consolidation is part of ongoing network optimization. The balance sheet is genuinely strong — $882M cash (+17%), a 3.7x current ratio, LT debt roughly flat at $1.19B (net debt only ~$310M), and aggressive capital return ($155M buybacks cut the share count 4%, with $46.5M still authorized).

The catch is durability. Management's own non-GAAP numbers temper the GAAP optics: adjusted operating income rose 19% (not 34.9%) and adjusted EPS was $2.73 vs $2.13 — the GAAP growth is flattered by lapped prior-year charges and easy comps. You cannot cut your way to growth forever; the declining ~$3.1B revenue base must eventually stabilize. Operating cash flow actually fell 15.8% to $333M, so the earnings jump hasn't yet flowed through to cash, though FCF (~$292M after $41M capex) is still a healthy ~10% yield on the $2.81B cap.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$3.30B$3.34B$3.31B$3.20B$3.13B
Gross profit$971M$992M$947M$944M$997M
Operating income$254M$260M$211M$185M$250M
Net income$152M$152M$126M$108M$163M
Diluted EPS$2.75$2.24$1.88$1.62$2.55
Net margin4.6%4.6%3.8%3.4%5.2%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$3.12B
EV / EBITDA9.3
EV / Sales1.0
EV / FCF10.7
P / FCF9.7
PEG (trailing)0.34
Earnings yield5.8%
FCF yield10.3%

Quality & risk

ROIC (est.)7.1%
Free cash flow$291M
Total debt$1.19B
Net cash-$309M
Piotroski F-Score8/9

Capital returns

Buyback yield5.5%
Dividend yield (est.)—
Shareholder yield5.5%
Shares Δ YoY-4.0%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has been improving.
  1. 10-Q Quarterly report2026-05-07

    Q2 FY26 (period 3/28/26): latest filing extends profitability gains

  2. 8-K Earnings results2026-05-06

    Q2 FY26 results released; latest quarter (period 3/28/26) continues margin focus

  3. 8-K Officer / director change2026-02-18

    Annual meeting vote results plus officer/board changes disclosed

  4. 10-Q Quarterly report2026-02-05

    Q1 FY26 quarterly detail filed after prior year's record results

  5. 8-K Earnings results2026-02-04

    Q1 FY26 earnings released, opening the new fiscal year

  6. DEF 14A Proxy statement2025-12-22

    Proxy: board slate and executive comp put to annual shareholder vote

  7. 10-K Annual report2025-11-26

    FY25 10-K: net income $163M, $148M buyback, UK wind-down, network optimization

  8. 8-K Earnings results2025-11-24

    FY25 results: net income +51% to $163M, EPS $2.55, gross margin +240bps

  9. 8-K Material agreement2025-11-12

    Entered material agreement creating new debt obligation (credit facility/refi)

Recent filings

all on EDGAR ↗
4Period ending 2026-06-242026-06-26open ↗4Period ending 2026-06-152026-06-17open ↗11-KPeriod ending 2025-12-312026-06-17open ↗4Period ending 2026-05-162026-05-19open ↗10-QPeriod ending 2026-03-282026-05-07open ↗8-KPeriod ending 2026-05-062026-05-06open ↗SCHEDULE 13GFiling2026-04-29open ↗SCHEDULE 13GFiling2026-04-29open ↗SCHEDULE 13GFiling2026-04-29open ↗4Period ending 2026-03-252026-03-26open ↗SCHEDULE 13G/AFiling2026-03-26open ↗SCHEDULE 13G/AFiling2026-03-26open ↗

Quality score

B
ValueGrowthProfitHealthMom.
ValueA
GrowthB-
ProfitabilityC+
Financial healthA-
Momentum—
  • ✗Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓P/E below 25

Fair value est.

$96.90

Undervalued +117% vs price

cheapfair valueexpensive

Modified Graham: EPS $2.55 × (8.5 + 1.5 × 22.0% growth) × 1.00 quality = 38.0× multiple. An estimate, not a price target.

Revenue
$3.13B
-2.2% YoY
Net margin
5.2%
ROE
10.3%
P/E
17.5

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$3.13B-2.2%
Net income$163M+50.8%
Gross profit$997M+5.7%
Operating income$250M+34.9%
Diluted EPS$2.55+57.4%
Cash & equivalents$882M+17.1%
Total assets$3.63B+2.0%
Stockholders' equity$1.58B+1.8%
Gross: 31.9%Op.: 8.0%

Frequently asked

Is CENTRAL GARDEN & PET CO (CENT) a buy?
CENT currently carries a Hold rating with 4/5 conviction, derived from its latest SEC filings. Quality self-help story: margins and EPS surging on cost cuts, but revenue's fallen four straight years — fair price, own don't chase.
What is CENT's fair value?
A Modified-Graham model based on CENT's SEC fundamentals estimates a fair value of about $96.90. It is an estimate from reported earnings, not a price target.
Is CENT overvalued or undervalued?
Against a Modified-Graham fair-value estimate, CENT currently appears undervalued relative to its SEC-grounded earnings power.
What is CENTRAL GARDEN & PET CO's quality score?
CENT scores 71.86274509803921/100 (grade B) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000887733, latest 10-Q filed 2026-05-07) · EODHD · analysis by claude-code · as of 6/30/2026, 3:31:47 AM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-06-24
Hanson John Edward
President, Pet Consumer Prod
Exercise8.52K @ $35.22$300K
2026-06-24
Hanson John Edward
President, Pet Consumer Prod
Tax8.05K @ $38.85$313K
2026-06-15
Walker John D. III
President, Garden Consumer Pro
Exercise8.52K @ $35.22$300K
2026-06-15
Walker John D. III
President, Garden Consumer Pro
Tax8.20K @ $37.75$310K
2026-05-16
LAHANAS NICHOLAS
Chief Executive Officer
Tax480.00 @ $34.19$16.4K
2026-03-25
BROWN WILLIAM E
Chairman
Gift2.04K
2026-03-13
Schwichtenberg Kay
Director
Award3.73K
2026-02-19
Ranelli John
Director
Sell3.67K @ $34.50$127K
2026-02-17
Hanson John Edward
President, Pet Consumer Prod
Sell5.00K @ $34.75$174K
2026-02-13
PENNINGTON BROOKS III
Director
Gift2.05K

Dividends

Irregular
Yield (TTM)
—
Annual / share
—
Last ex-date
2007-02-06
Last amount
$22.87
ex 2007-02-06$22.87

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-05-06Beat +15.4% est▲ +2.05%8-K ↗
2026-02-04Beat +49.1% est▲ +1.83%8-K ↗
2025-11-24Beat +54.8% est▼ -2.66%8-K ↗
2025-08-06Beat +7.2% est▼ -0.53%8-K ↗
2025-07-11Beat +7.2% est▲ +9.88%8-K ↗
2025-05-07—▼ -0.29%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

Disclosed under the STOCK Act

2021-05-07Josh GottheimerSell$1.00K–$15.0KPTR ↗
2020-06-10Josh GottheimerSell$1.00K–$15.0KPTR ↗
2020-02-18Gilbert CisnerosBuy$15.0K–$50.0KPTR ↗
2020-02-10Josh GottheimerBuy$1.00K–$15.0KPTR ↗
2020-01-10Gilbert CisnerosSell$1.00K–$15.0KPTR ↗
2020-01-06Josh GottheimerSell$1.00K–$15.0KPTR ↗
2019-10-16Gilbert CisnerosBuy$1.00K–$15.0KPTR ↗
2019-03-08Gilbert CisnerosBuy$1.00K–$15.0KPTR ↗
2018-10-02Josh GottheimerBuy$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Recent news

market news →
Are Consumer Discretionary Stocks Lagging Alto Ingredients (ALTO) This Year?Bullish
finance.yahoo.com· 2026-06-29
Central Garden & Pet (CENT): Buy, Sell, or Hold Post Q1 Earnings?Bullish
finance.yahoo.com· 2026-06-26
Chewy vs. Central Garden & Pet: Which Pet-Care Stock Has an Edge?Bullish
finance.yahoo.com· 2026-06-24
A Look Back at Household Products Stocks’ Q1 Earnings: Central Garden & Pet (NASDAQ:CENT) Vs The Rest Of The PackBullish
finance.yahoo.com· 2026-06-23
Chewy's Autoship Program Continues to Drive Customer GrowthBullish
finance.yahoo.com· 2026-06-18
Chewy Stock Tumbles 45% in 3 Months: What Should Investors Do Now?Bullish
finance.yahoo.com· 2026-06-18

Vs tracked universe

compare →

1053 tracked peers · median

EDGAR Score72 vs 67
Revenue growth-2.2% vs 7.1%
Net margin5.2% vs 10.4%
Return on equity10.3% vs 12.3%
P/E17.5 vs 25.3

News sentiment

EODHD · 27d
Bullish
+0.18
vs typical · 45 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.